Clinical trial

Metformin to Treat Obesity in Children With Insulin Resistance

NCT00005669 · Jack Yanovski, M.D., NIH · Completed

Key facts

NCT number NCT00005669
Title Metformin to Treat Obesity in Children With Insulin Resistance
Official title Effects of Metformin on Energy Intake, Energy Expenditure, and Body Weight in Overweight Children With Insulin Resistance
Lead sponsor Jack Yanovski, M.D., NIH
Collaborators Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Hyperinsulinemia, Obesity
Intervention type Drug
Interventions Metformin HCL, Placebo
Enrollment 100
Start date May 1, 2000
Primary completion Aug 1, 2009
Completion May 1, 2011
First posted May 22, 2000
Last update posted May 8, 2015
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies